UBS Group’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-58,035
| Closed | -$1.62M | – | 7466 |
|
2019
Q3 | $1.62M | Buy |
58,035
+57,191
| +6,776% | +$1.6M | ﹤0.01% | 2802 |
|
2019
Q2 | $12K | Buy |
844
+544
| +181% | +$7.74K | ﹤0.01% | 6110 |
|
2019
Q1 | $3K | Sell |
300
-1,534
| -84% | -$15.3K | ﹤0.01% | 6560 |
|
2018
Q4 | $14K | Sell |
1,834
-445
| -20% | -$3.4K | ﹤0.01% | 6145 |
|
2018
Q3 | $48K | Buy |
2,279
+1,279
| +128% | +$26.9K | ﹤0.01% | 5304 |
|
2018
Q2 | $30K | Buy |
+1,000
| New | +$30K | ﹤0.01% | 5483 |
|
2017
Q4 | – | Sell |
-94
| Closed | -$2K | – | 7105 |
|
2017
Q3 | $2K | Sell |
94
-2,406
| -96% | -$51.2K | ﹤0.01% | 6596 |
|
2017
Q2 | $56K | Buy |
+2,500
| New | +$56K | ﹤0.01% | 4665 |
|